Clinical applications of heart rhythm monitoring tools in symptomatic patients and for screening in high-risk groups
(2022) In Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 24(11). p.1721-1729- Abstract
Recent technological advances have facilitated and diversified the options available for the diagnosis of cardiac arrhythmias. Ranging from simple resting or exercise electrocardiograms to more sophisticated and expensive smartphones and implantable cardiac monitors. These tests and devices may be used for varying periods of time depending on symptom frequency. The choice of the most appropriate heart rhythm test should be guided by clinical evaluation and optimized following accurate characterization of underlying symptoms, 'red flags', risk factors, and consideration of cost-effectiveness of the different tests. This review provides evidence-based guidance for assessing suspected arrhythmia in patients who present with symptoms or in... (More)
Recent technological advances have facilitated and diversified the options available for the diagnosis of cardiac arrhythmias. Ranging from simple resting or exercise electrocardiograms to more sophisticated and expensive smartphones and implantable cardiac monitors. These tests and devices may be used for varying periods of time depending on symptom frequency. The choice of the most appropriate heart rhythm test should be guided by clinical evaluation and optimized following accurate characterization of underlying symptoms, 'red flags', risk factors, and consideration of cost-effectiveness of the different tests. This review provides evidence-based guidance for assessing suspected arrhythmia in patients who present with symptoms or in the context of screening, such as atrial fibrillation or advanced conduction disturbances following transcatheter aortic valve implantation in high-risk groups. This is intended to help clinicians choose the most appropriate diagnostic tool to facilitate the management of patients with suspected arrhythmias.
(Less)
- author
- Carrington, Mafalda ; Providência, Rui ; Chahal, C Anwar A ; Ricci, Fabrizio LU ; Epstein, Andrew E ; Gallina, Sabina ; Fedorowski, Artur LU ; Sutton, Richard LU and Khanji, Mohammed Y
- organization
- publishing date
- 2022
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
- volume
- 24
- issue
- 11
- pages
- 1721 - 1729
- publisher
- Oxford University Press
- external identifiers
-
- pmid:35983729
- scopus:85142918772
- ISSN
- 1532-2092
- DOI
- 10.1093/europace/euac088
- language
- English
- LU publication?
- yes
- additional info
- © The Author(s) 2022. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For permissions, please email: journals.permissions@oup.com.
- id
- b739e458-3104-48ca-b499-57af33def48c
- date added to LUP
- 2022-08-26 19:12:08
- date last changed
- 2024-09-18 08:43:40
@article{b739e458-3104-48ca-b499-57af33def48c, abstract = {{<p>Recent technological advances have facilitated and diversified the options available for the diagnosis of cardiac arrhythmias. Ranging from simple resting or exercise electrocardiograms to more sophisticated and expensive smartphones and implantable cardiac monitors. These tests and devices may be used for varying periods of time depending on symptom frequency. The choice of the most appropriate heart rhythm test should be guided by clinical evaluation and optimized following accurate characterization of underlying symptoms, 'red flags', risk factors, and consideration of cost-effectiveness of the different tests. This review provides evidence-based guidance for assessing suspected arrhythmia in patients who present with symptoms or in the context of screening, such as atrial fibrillation or advanced conduction disturbances following transcatheter aortic valve implantation in high-risk groups. This is intended to help clinicians choose the most appropriate diagnostic tool to facilitate the management of patients with suspected arrhythmias.</p>}}, author = {{Carrington, Mafalda and Providência, Rui and Chahal, C Anwar A and Ricci, Fabrizio and Epstein, Andrew E and Gallina, Sabina and Fedorowski, Artur and Sutton, Richard and Khanji, Mohammed Y}}, issn = {{1532-2092}}, language = {{eng}}, number = {{11}}, pages = {{1721--1729}}, publisher = {{Oxford University Press}}, series = {{Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology}}, title = {{Clinical applications of heart rhythm monitoring tools in symptomatic patients and for screening in high-risk groups}}, url = {{http://dx.doi.org/10.1093/europace/euac088}}, doi = {{10.1093/europace/euac088}}, volume = {{24}}, year = {{2022}}, }